Literature DB >> 17068457

Prevention of corneal neovascularization: evaluation of various commercially available compounds in an experimental rat model.

Mohammad Riazi-Esfahani1, Gholam A Peyman, Erdinc Aydin, Abdul Ahad Kazi, Muhamet Kivilcim, Donald R Sanders.   

Abstract

PURPOSE: To evaluate the effect of topically administered agents doxycycline, triamcinolone, low molecular weight heparin (LMWH), and flurbiprofen on experimental corneal neovascularization in rats.
METHODS: Chemical cauterization of cornea was performed in 36 eyes of 36 rats by using silver nitrate/potassium nitrate sticks. Topical instillation of doxycycline, triamcinolone, LMWH, flurbiprofen, and normal saline solution was continued for 7 days. Percent areas of cornea covered by neovascularization and covered by scar in each group were calculated by use of computer software on digital photographs. Groups were compared for any significant (P < 0.05) differences among them.
RESULTS: The means of percent area of corneal neovascularization in triamcinolone, doxycycline, flurbiprofen, LMWH, and control groups were 13.3%, 35.5%, 50.6%, 66.7%, and 74.9%, respectively. The triamcinolone and doxycycline groups were different from control group (P < 0.05). There was no significant difference in the percent area of neovascularization between the LMWH and flurbiprofen groups compared with the controls. Although the effects of LMWH and flurbiprofen were not significant, there seemed to be a trend, and the lack of significance may be related to small sample size. Because the mechanisms of action of these agents are not identical to each other, performing other studies using combinations of them seems to be reasonable. There were no significant differences in percent area of corneal scar among groups.
CONCLUSION: Topical instillation of commercially available triamcinolone and doxycycline seems to diminish corneal neovascularization caused by chemical cauterization of cornea in rats.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17068457     DOI: 10.1097/01.ico.0000220768.11778.60

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  6 in total

1.  Topical dihydroartemisinin inhibits suture-induced neovascularization in rat corneas through ERK1/2 and p38 pathways.

Authors:  Yan-Yan Zhong; Hai-Feng Zhang; Jia-Xi Zhong; Lang Bai; Xiao-He Lu
Journal:  Int J Ophthalmol       Date:  2011-04-18       Impact factor: 1.779

2.  Doxycycline's effect on ocular angiogenesis: an in vivo analysis.

Authors:  Constance A Cox; Juan Amaral; Rita Salloum; Liliana Guedez; Ted W Reid; Cindy Jaworski; Moly John-Aryankalayil; Ken A Freedman; Mercedes M Campos; Alfredo Martinez; Susan P Becerra; Deborah A Carper
Journal:  Ophthalmology       Date:  2010-06-03       Impact factor: 12.079

3.  The effect of bevacizumab on corneal neovascularization in rabbits.

Authors:  Wung-Jae Kim; Hee-Ok Jeong; Sung-Kun Chung
Journal:  Korean J Ophthalmol       Date:  2010-08-03

4.  Attenuation of corneal neovascularization by topical low-molecular-weight heparin-taurocholate 7 without bleeding complication.

Authors:  Jae Yong Kim; Soo Yeon Kim; Mi Hyun Cheon; Eun-Soon Kim; In Seok Song; Myoung Joon Kim; Hungwon Tchah
Journal:  Int J Ophthalmol       Date:  2016-09-18       Impact factor: 1.779

Review 5.  Corneal transparency: genesis, maintenance and dysfunction.

Authors:  Yureeda Qazi; Gilbert Wong; Bryan Monson; Jack Stringham; Balamurali K Ambati
Journal:  Brain Res Bull       Date:  2009-05-27       Impact factor: 4.077

6.  Comparison of subconjunctivally injected bevacizumab, ranibizumab, and pegaptanib for inhibition of corneal neovascularization in a rat model.

Authors:  Ebru Eren Akar; Veysi Oner; Cem Küçükerdönmez; Yonca Aydın Akova
Journal:  Int J Ophthalmol       Date:  2013-04-18       Impact factor: 1.779

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.